Clinical Trial Update: Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating trigeminal nerve stimulation for Attention-Deficit/Hyperactivity Disorder has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Trigeminal Nerve Stimulation (trigeminal nerve stimulation)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Attention-Deficit/Hyperactivity Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2016-04-11